Detecting type 1 diabetes early using advanced technology
Early detection of type 1 diabetes via Exosome Technology with Optoelectronics Lab-on-chip: EXTOL
This study is testing a new way to spot early signs of type 1 diabetes by looking at tiny particles from your cells, which could help people get diagnosed sooner and manage their condition better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11085286 on NIH RePORTER |
What this research studies
This research focuses on the early detection of type 1 diabetes (T1D) by utilizing a novel technology that analyzes exosomes, which are small particles released by cells. The approach involves creating a system that can efficiently isolate and identify these exosomes from pancreatic beta cells, which may indicate early signs of T1D before symptoms appear. By combining various biomarkers, the research aims to improve the accuracy of early diagnosis and potentially reduce the duration of clinical trials for new treatments. Patients may benefit from a more timely diagnosis and better management of their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of developing type 1 diabetes, particularly those with a family history or genetic predisposition.
Not a fit: Patients who are already diagnosed with type 1 diabetes or those without any risk factors for the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of type 1 diabetes, allowing for timely interventions that may improve patient outcomes.
How similar studies have performed: Previous research has shown promise in using biomarkers for early detection of autoimmune diseases, suggesting that this approach may yield successful outcomes.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Lee, Luke P. — Brigham and Women's Hospital
- Study coordinator: Lee, Luke P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.